Declan Devane1, Cecily M Begley, Mike Clarke. 1. School of Nursing and Midwifery Studies, University of Dublin Trinity College, Dublin, Ireland. ddevane@tcd.ie
Abstract
BACKGROUND: In conducting randomized trials, formal estimations of sample size are required to ensure that the probability of missing an important difference is small, to reduce unnecessary cost and to reduce wastage. Nevertheless, this aspect of research design often causes confusion for the novice researcher. AIM: This paper attempts to demystify the process of sample size estimation by explaining some of the basic concepts and issues to consider in determining appropriate sample sizes. METHOD: Using a hypothetical two group, randomized trial as an example, we examine each of the basic issues that require consideration in estimating appropriate sample sizes. Issues discussed include: the ethics of randomized trials, the randomized trial, the null hypothesis, effect size, probability, significance level and type I error, and power and type II error. The paper concludes with examples of sample size estimations with varying effect size, power and alpha levels. CONCLUSION: Health care researchers should carefully consider each of the aspects inherent in sample size estimations. Such consideration is essential if care is to be based on sound evidence, which has been collected with due consideration of resource use, clinically important differences and the need to avoid, as far as possible, types I and II errors. If the techniques they employ are not appropriate, researchers run the risk of misinterpreting findings due to inappropriate, unrepresentative and biased samples.
BACKGROUND: In conducting randomized trials, formal estimations of sample size are required to ensure that the probability of missing an important difference is small, to reduce unnecessary cost and to reduce wastage. Nevertheless, this aspect of research design often causes confusion for the novice researcher. AIM: This paper attempts to demystify the process of sample size estimation by explaining some of the basic concepts and issues to consider in determining appropriate sample sizes. METHOD: Using a hypothetical two group, randomized trial as an example, we examine each of the basic issues that require consideration in estimating appropriate sample sizes. Issues discussed include: the ethics of randomized trials, the randomized trial, the null hypothesis, effect size, probability, significance level and type I error, and power and type II error. The paper concludes with examples of sample size estimations with varying effect size, power and alpha levels. CONCLUSION: Health care researchers should carefully consider each of the aspects inherent in sample size estimations. Such consideration is essential if care is to be based on sound evidence, which has been collected with due consideration of resource use, clinically important differences and the need to avoid, as far as possible, types I and II errors. If the techniques they employ are not appropriate, researchers run the risk of misinterpreting findings due to inappropriate, unrepresentative and biased samples.
Authors: Kathy Murphy; Dympna Casey; Declan Devane; Adeline Cooney; Bernard McCarthy; Lorraine Mee; Martina Nichulain; Andrew W Murphy; John Newell; Eamon O' Shea Journal: BMC Pulm Med Date: 2011-01-18 Impact factor: 3.317
Authors: Usama Ahmed Ali; Yama Issa; Marco J Bruno; Harry van Goor; Hjalmar van Santvoort; Olivier R C Busch; Cornelis H C Dejong; Vincent B Nieuwenhuijs; Casper H van Eijck; Hendrik M van Dullemen; Paul Fockens; Peter D Siersema; Dirk J Gouma; Jeanin E van Hooft; Yolande Keulemans; Jan W Poley; Robin Timmer; Marc G Besselink; Frank P Vleggaar; Oliver H Wilder-Smith; Hein G Gooszen; Marcel G W Dijkgraaf; Marja A Boermeester Journal: BMC Gastroenterol Date: 2013-03-18 Impact factor: 3.067
Authors: Annemarije L Kruis; Melinde R S Boland; Catharina H Schoonvelde; Willem J J Assendelft; Maureen P M H Rutten-van Mölken; Jacobijn Gussekloo; Apostolos Tsiachristas; Niels H Chavannes Journal: BMC Pulm Med Date: 2013-03-23 Impact factor: 3.317
Authors: Annemarije L Kruis; Melinde R S Boland; Willem J J Assendelft; Jacobijn Gussekloo; Apostolos Tsiachristas; Theo Stijnen; Coert Blom; Jacob K Sont; Maureen P H M Rutten-van Mölken; Niels H Chavannes Journal: BMJ Date: 2014-09-10